Design and development of galantamine hydrobromide transdermal patch for treatment of alzheimer’s disease
Alzheimer’s disease (AD) is a neurodegenerative disease, which is caused by abnormal accumulation of beta amyloid (Aβ) peptide in brain and degeneration of cholinergic neurons. Galantamine hydrobromide (GH) is an effective drug for the treatment of AD with its function as the acetylcholinesterase en...
Saved in:
Main Author: | Woo, Fong Yen |
---|---|
Format: | Thesis |
Language: | English |
Published: |
2015
|
Subjects: | |
Online Access: | http://psasir.upm.edu.my/id/eprint/65408/1/FS%202015%2045IR.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Design, synthesis and anti-acetylcholinesterase evaluation of new coumarin hybrids as potential agents for the treatment of alzheimer disease
by: Hasan, Aso Hameed
Published: (2021) -
Preparation, characterization and pharmacokinetic release of diclofenac sodium-dual layer polyvinyl alcohol patch for transdermal delivery
by: Sa'adon, Shafizah
Published: (2022) -
Alzheimer disease biomarker based on carotid artery reactivity
by: Jamlos, Mohd. Aminudin
Published: (2012) -
Development of hippocampus MRI image segmentation algorithm for progression detection of alzheimer’s disease (AD)
by: Gilani Mohamed, Mohamed Ahmed
Published: (2022) -
Pharmacokinetic studies for the development of transdermal drug delivery systems /
by: Zamri Chik
Published: (2007)